Abstract
Advances in personalised medicine targeting specific sub-populations and individuals pose a challenge to the traditional pharmaceutical industry. With a higher level of personalisation, an already critical supply chain is facing additional demands added by the very sensitive nature of its products. Nevertheless, studies concerned with the efficient development and delivery of these products are scarce. Thus, this paper presents the case of personalised medicine and the challenges imposed by its mass delivery. We propose a multi-objective mathematical model for the location-allocation problem with two interdependent facility types in the case of personalised medicine products. We show its practical application through a cell and gene therapy case study. A multi-objective genetic algorithm with a novel population initialisation procedure is used as solution method.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsNotes
- 1.
A temperature-controlled supply chain that maintains a product viable through decreases in temperature.
- 2.
Code for both MOO algorithms is available at doi: 10.5281/zenodo.4495163.
References
Abou-El-Enein, M., Elsanhoury, A., Reinke, P.: Overcoming challenges facing advanced therapies in the EU market. Cell Stem Cell 19(3), 293–297 (2016)
Ahmadi-Javid, A., Seyedi, P., Syam, S.S.: A survey of healthcare facility location. Comput. Oper. Res. 79, 223–263 (2017)
Ardjmand, E., Weckman, G.R., Park, N., Taherkhani, P., Manjeet, S.: Applying genetic algorithm to a new location and routing model of hazardous materials. Int. J. Prod. Res. 53, 916–928 (2015)
Basu, S., Sharma, M., Ghosh, P.S.: Metaheuristic applications on discrete facility location problems: a survey. Opsearch 52(3), 530–561 (2014). https://doi.org/10.1007/s12597-014-0190-5
Bersenev, A., Kili, S.: Management of ‘out of specification’ commercial autologous CAR-T cell products. Cell Gene Therapy Insights 4(11), 1051–1058 (2018)
Bhattacharya, R., Bandyopadhyay, S.: Solving conflicting bi-objective facility location problem by NSGA II evolutionary algorithm. Int. J. Adv. Manuf. Technol. 51(1–4), 397–414 (2010)
Burkholder, T.W., Hill, K., Hynes, E.J.C.: Developing emergency care systems: a human rights-based approach. Bull. World Health Organ. 97(9), 612–619 (2019)
CBER: Kymriah (tisagenlecleucel) (2017). https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/kymriah-tisagenlecleucel. Accessed 20 Sept 2020
Deb, K., Pratap, A., Agarwal, S., Meyarivan, T.: A fast and elitist multi-objective genetic algorithm: NSGA-II. IEEE Trans. Evol. Comput. 6(2), 182–197 (2002)
Doerner, K.F., Gutjahr, W.J., Nolz, P.C.: Multi-criteria location planning for public facilities in tsunami-prone coastal areas. OR Spectrum 31(3), 651–678 (2008)
Eder, C., Wild, C.: Technology forecast: advanced therapies in late clinical research, EMA approval or clinical application via hospital exemption. J. Market Access Health Policy 7(1), 1600939 (2019)
Eghbali, M., Abedzadeh, M., Setak, M.: Multi-objective reliable hub covering location considering customer convenience using NSGA-II. Int. J. Syst. Assur. Eng. Manage. 5(3), 450–460 (2013). https://doi.org/10.1007/s13198-013-0189-y
Ermak, G.: Emerging medical technologies. World Scientific (2016)
Farahani, R.Z., SteadieSeifi, M., Asgari, N.: Multiple criteria facility location problems: a survey. Appl. Math. Model. 34, 1689–1709 (2010)
Gonçalves, E.: Advanced therapy medicinal products: value judgement and ethical evaluation in health technology assessment. Eur. J. Health Econ. 21(3), 311–320 (2020). https://doi.org/10.1007/s10198-019-01147-x
Hanley, P.J.: Fresh versus frozen: effects of Cryopreservation on CAR T Cells. Mol. Therapy 27(7), 1213–1214 (2019), ISSN 15250024
Hiassat, A., Diabat, A., Rahwan, I.: A genetic algorithm approach for location-inventory-routing problem with perishable products. J. Manuf. Syst. 42, 93–103 (2017)
Jarosławski, S., Toumi, M.: Sipuleucel-t (Provenge) - Autopsy of an Innovative Paradigm Change in Cancer Treatment: Why a Single-Product Biotech Company Failed to Capitalize on its Breakthrough Invention. BioDrugs 29(5), 301–307 (2015)
Lander, E.S., Linton, L.M., Birren, B.: Initial sequencing and analysis of the human genome. Nature 409(6822), 860–921 (2001)
Lopes, A.G., Noel, R., Sinclair, A.: Cost analysis of vein-to-vein CAR T-cell therapy: automated manufacturing and supply chain. Cell Gene Therapy Insights 6(3), 487–510 (2020)
Medaglia, A.L., Villegas, J.G., Rodríguez-Coca, D.M.: Hybrid biobjective evolutionary algorithms for the design of a hospital waste management network. Journal of Heuristics 15(2), 153–176 (2009)
Nematollahi, M., Hosseni-Motlagh, S.M., Heydari, J.: Economic and social collaborative decision-making on visit interval and service level in a two-echelon pharmaceutical supply chain. J. Clean. Prod. 142, 3956–3969 (2017)
Panch, S.R., et al.: Effect of cryopreservation on autologous chimeric antigen receptor T-Cell characteristics. Mol. Therapy 27(7), 1275–1285 (2019), ISSN 15250024
Papathanasiou, M.M., Stamatis, C., Lakelin, M., Farid, S., Titchener-Hooker, N., Shah, N.: Autologous CAR T-cell therapies supply chain: challenges and opportunities? Cancer Gene Ther. 27(10–11), 799–809 (2020)
Pirabán, A., Guerrero, W.J., Labadie, N.: Survey on blood supply chain management: models and methods. Comput. Oper. Res. 112, 104756 (2019)
Quinn, C., Young, C., Thomas, J., Trusheim, M.: Estimating the Clinical Pipeline of Cell and Gene Therapies and Their Potential Economic Impact on the US Healthcare System. Value Health 22(6), 621–626 (2019)
Rahmani, A., Mirhassani, S.: A hybrid Firefly-Genetic Algorithm for the capacitated facility location problem. Inf. Sci. 283, 70–78 (2014)
Redekop, W.K., Mladsi, D.: The faces of personalized medicine: a framework for understanding its meaning and scope. Value Health 16(6), (2013)
Alliance for Regenerative Medicine: Clinical Trials in Europe: Recent Trends in ATMP Development. Technical report ARM, October 2019
Sexauer, A., Sandlund, J.T., Marcus, K.J.: Paediatric Leukemia and Lymphoma. In: Gunder’s & Tepper’s Clinical Radiation Oncology, pp. 1468–1476, Elsevier (2020)
Sinclair, A., Monge, M.: Measuring Manufacturing Cost and Its Impact on Organizations. BioProcess International, p. 36–44 (2010)
Steliarova-Fourcher, E., Colombet, M., Ries, L., Moreno, F., Dolya, A., Bray, F., et. al.: International incidence of childhood cancer, 2001–2010: a population based registry study. Lancet Oncol. 18(6), 719–731 (2017)
Sun, W., Malvar, J., Sposto, R., Verma, A., et al.: Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study. Leukemia 32(11), 2316–2325 (2018)
Villegas, J.G., Palacios, F., Medaglia, A.L.: Solution methods for the bi-objective (cost-coverage) unconstrained facility location problem with an illustrative example. Ann. Oper. Res. 147(1), 109–141 (2006)
Wang, B., Liang, Y., Zheng, T., Yuan, M., Zhang, H.: Multi-objective site selection optimization of the gas-gathering station using nsga-ii. Process Saf. Environ. Prot. 119, 350–359 (2018)
Wang, X., Kong, Q., Papathanasiou, M.M., Shah, N.: Precision healthcare supply chain design through multi-objective stochastic programming. 13th International Symposium on Process Systems Engineering (PSE 2018) Computer Aided Chemical Engineering, p. 2137–2142 (2018)
Weiss, D., Rydland, H.T., Øversveen, E., Jensen, M.R., Solhaug, S., Krokstad, S.: Innovative technologies and social inequalities in health: A scoping review of the literature. PLoS One 13(4), e0195447 (2018)
Wilson, B., Nicholls, S.G.: The Human Genome Project, and recent advances in personalized genomics. Risk Management and Healthcare Policy, p. 9–20 (2015)
Yang, L., Jones, B.F., Yang, S.H.: A fuzzy multi-objective programming for optimization of fire station locations through genetic algorithms. Eur. J. Oper. Res. 181(2), 903–915 (2007)
Ebrahimi Zade, A., Sadegheih, A., Lotfi, M.M.: A modified NSGA-II solution for a new multi-objective hub maximal covering problem under uncertain shipments. J. Ind. Eng. Int. 10(4), 185–197 (2014). https://doi.org/10.1007/s40092-014-0076-4
Acknowledgements
We thank Biopharm Services for their assistance with this project. Biopharm provided us with extensive datasets and invaluable feedback on the research. Their contribution has significantly increased the quality and accuracy of this paper. M. López-Ibáñez is a “Beatriz Galindo” Senior Distinguished Researcher (BEAGAL 18/00053) funded by the Ministry of Science and Innovation of the Spanish Government.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this paper
Cite this paper
Avramescu, A., Allmendinger, R., López-Ibáñez, M. (2021). A Multi-objective Multi-type Facility Location Problem for the Delivery of Personalised Medicine. In: Castillo, P.A., Jiménez Laredo, J.L. (eds) Applications of Evolutionary Computation. EvoApplications 2021. Lecture Notes in Computer Science(), vol 12694. Springer, Cham. https://doi.org/10.1007/978-3-030-72699-7_25
Download citation
DOI: https://doi.org/10.1007/978-3-030-72699-7_25
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-72698-0
Online ISBN: 978-3-030-72699-7
eBook Packages: Computer ScienceComputer Science (R0)